Dr. Von Hoff is currently Physician-in-Chief and Distinguished Professor at TGen (Translational Genomics Research Institute) in Phoenix, Arizona. Dr. Von Hoff’s major interest is in the development of anticancer agents. He and his colleagues were involved in concept and development of many of the agents now used routinely in cancer care, including: mitoxantrone, fludarabine, paclitaxel, docetaxel, gemcitabine, irinotecan, nelarabine, capecitabine, lapatinib, vismodegib, nab-paclitaxel, nal-lRI, and others. Winner of the prestigious Karnofsky award for outstanding achievements in cancer research and impact on treatment of cancer patients.

Dr. Finn is the Interim Director of Ochsner’s Hematology and Bone Marrow Transplant Program. She completed a Hematology/Oncology fellowship at the Mayo Clinic in Jacksonville, FL where she was chief fellow and remained on faculty for two years as an Assistant Professor of Medicine. She completed advanced training in Bone Marrow Transplant at the University of Minnesota. She is the author of numerous peer reviewed publications in Hematology, Bone Marrow Transplant and use of Palliative Medicine in cancer care and speaks globally on these topics. As a clinical investigator, Dr. Finn is focused on therapeutic trials for the treatment of hematologic malignancies and enhancement of bone marrow transplant.

Dr. Katrina Wade’s area of clinical expertise is gynecologic cancers, including cervical, uterine, vulvar and ovarian cancer, as well as gestational trophoblastic disease. She is board certified in gynecologic oncology and has been recognized for her research in the field of gynecologic oncology. She is widely published in peer-reviewed medical journals and serves on the Ovarian Cancer committee for NRG oncology. Dr. Wade strongly believes in a multidisciplinary team approach to gynecologic cancer care. She seeks to provide women with the most advanced and personalized treatment plans while best preserving quality of life.

Erin Pierce received a Master of Science in Nursing from the University of South Alabama and a Bachelor of Science in Nursing from Louisiana State University. Prior to joining the Hematology/Oncology team as a nurse practitioner, Erin worked as a registered nurse for Ochsner's chemotherapy infusion. She currently serves as a sub-investigator for over 80 clinical trials and is the first advanced practice provider serving as a primary investigator on an early phase cancer clinical trial in the state of Louisiana. After both of her parents were diagnosed with cancer, Erin was inspired to become an oncology nurse practitioner and has devoted her career to fighting cancer, which sparked her interest in clinical cancer research and drug development. She was chosen as the 2018 Ochsner Advanced Practice Provider of the Year for her research contributions.

Elsa Levenes has been the RN clinical research supervisor for the Precision Cancer Therapies Program since 2016. She started working in oncology in 2008, first as an inpatient oncology nurse, then as an outpatient chemotherapy infusion nurse and then as an oncology clinical research coordinator.

Jessica Rentfrow is a clinical research coordinator for the Precision Cancer Therapies Program specializing in genitourinary and breast cancers. She has been working in oncology since 2015 and joined the Ochsner PCTP in 2016.

Megan Klobucar is a clinical research coordinator for the Precision Cancer Therapies Program specializing in early and late phase hematology clinical trials. She has worked in oncology since 2008 after working in the inpatient oncology unit and then as a chemotherapy infusion nurse. She joined the Ochsner PCTP in 2021.

Carly Lang is an associate clinical research coordinator for the Precision Cancer Therapies Program. She is currently working on the Genzada trial for all disease sites as well as gene mutation studies, and she assists the clinical research team where needed. She joined the Ochsner PCTP in 2019.

Tayisa Davis has worked in hematology/oncology for Ochsner since 2014 and joined the PCTP team in 2020 as the access navigator. She performs direct outreach to patients, schedules appointments, manages referrals and provides support to staff and patients.

Jade Dennison is the data coordinator for the Precision Cancer Therapies Program with areas of research including all hematology studies as well as new GI and GU studies. She previously worked in the anatomic pathology department at Ochsner since 2019 and joined the PCTP in 2021.